Currently, NICE guidance addresses the use of these medications for weight management through specific technology appraisals, though there is limited guidance specifically for post-bariatric weight regain
Oral supplements and topical products are generally considered safe and effective, but the effectiveness can vary depending on the quality of the supplement and the bioavailability of the supplement
Additionally, there are both oral and injectable options, with injectable options that are dosed daily or weekly
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies
Wegovy se administra semanalmente y es ms eficaz cuando se combina con un plan de dieta y ejercicio